| Expression pattern: |
UP |
| Associated gene: |
SLC1A5, Ago2 |
| Associated microRNA: |
miR-516b-5p |
| Biological function: |
Promotes NSCLC cell proliferation, migration, invasion, tumor growth and glutamine metabolism, and inhibits apoptosis. |
| Molecular mechanism: |
circ-OXCT1 acts as a molecular sponge for miR-516b-5p and upregulates SLC1A5, thereby facilitating NSCLC progression and glutamine metabolism. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glutaminolysis (promotes); ceRNA regulation (other); other pathway/process (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; Bioinformatics Analysis |
| Clinical significance: |
provided a possible circRNA-targeted therapy for NSCLC |
| Description: |
circ-OXCT1 is upregulated in NSCLC tissues and cell lines. It promotes malignant phenotypes and glutamine metabolism while suppressing apoptosis, acting through a circ-OXCT1/miR-516b-5p/SLC1A5 regulatory axis. Knockdown of circ-OXCT1 also inhibits xenograft tumor growth, suggesting therapeutic relevance. |
| Confidence score: |
0.8006 |